Low adiponectin levels at baseline and decreasing adiponectin levels over 10 years of follow-up predict risk of the metabolic syndrome
- 1 April 2017
- journal article
- Published by Elsevier in Diabetes & Metabolism
- Vol. 43 (2) , 134-139
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Adiponectin: A multitasking player in the field of liver diseasesDiabetes & Metabolism, 2014
- C-Reactive Protein, High-Molecular-Weight Adiponectin and Development of Metabolic Syndrome in the Japanese General Population: A Longitudinal Cohort StudyPLOS ONE, 2013
- Adipose tissue as an endocrine organMolecular and Cellular Endocrinology, 2010
- Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseasesInternational Journal of Obesity, 2008
- Obesity and inflammation: the effects of weight lossNutrition Research Reviews, 2008
- Adipokines and Insulin ResistanceMolecular Medicine, 2008
- Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndromeJournal of Clinical Investigation, 2006
- Alterations in the dynamics of circulating ghrelin, adiponectin, and leptin in human obesityProceedings of the National Academy of Sciences, 2004
- Definition of Metabolic SyndromeCirculation, 2004
- Plasma Concentrations of a Novel, Adipose-Specific Protein, Adiponectin, in Type 2 Diabetic PatientsArteriosclerosis, Thrombosis, and Vascular Biology, 2000